Integra LifeSciences Announces Leadership Transition
Integra LifeSciences Holdings Corporation has announced a leadership transition with Stuart M. Essig appointed as the new president and CEO, effective May 1, 2026. He succeeds Mojdeh Poul, who is leaving for other opportunities. Additionally, Michael McBreen has been appointed as chief commercial officer, aiming to elevate the company’s commercial performance. The Board expressed confidence in Essig’s leadership to ensure continued growth and operational excellence.
Stuart Essig Appointed as Integra’s Next President and Chief Executive Officer
Michael McBreen Appointed Chief Commercial Officer